Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Can you beat 50% per month? -- Ignore unavailable to you. Want to Upgrade?

To: fella31 who wrote (8187)	6/13/2005 1:19:07 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 19256

I have a position in ICOR at .255--I have posted a few messages on the Yahoo board which may be useless, or not. I think it as good as any penny stock speculation, but happens to be in an area of biotech that should have a lot of promise over the next several years. "Systems biology" and "Biomarkers" are certainly more than just buzzwords, although I'm not sure that Icoria has enough cash and staff to really do much in the area. In any event, the stock should be delisted so if there is any interest in aquiring the company for their patents and such, that would be going on now--and the stock does seem to trade quite a few shares as it declines penny by penny. I've put as much into the thing as I can afford to lose without flinching. With something like 10m in the bank it can't go to zero right away--that is probably a year away. Biotech legend Leroy Hood sits on the BOD. That seems not to have helped so far, ha! Steve Burrill, biotech finacier and fund manager, also holds something like 100k shares, which isn't a lot at this price. I'd like to see the BOD buy shares on the open market at this price, so far has not happened.